OSIP wide-straddle per our newsletter, in front of so-called "earnings" Marketgems is doing the research for more "FDA anticipatory upswing" of optimism drug plays and of course looking for the "short the results" and short the results that ultimately disappoint. Thus far we have successfully had 3 pullbacks and 1 move up. Any medical professionals/traders out there that would like to join our research the 'overoptimistic' blimps or the actual potential blockbuster please email jenna@marketgems.com. We are full throttle here for biotechs. FDA pullbacks can be better than the former upside (QLTI, and IMCL were buys and holds) and NABI and VXGN are the occasional 1-2 day move but the big ones are the ones we want.
Market Data 
Markets 
AI
